Showing results (61-70 of 80) with videos related to
Sort By:
Pageof 8
Leukemia|February 24, 2018
Pharmacologic inhibition of STAT5 in acute myeloid leukemiaBettina Wingelhofer, Barbara Maurer, Elizabeth C Heyes, et al.Nature|June 4, 2025
Probing condensate microenvironments with a micropeptide killswitchYaotian Zhang, Ida Stöppelkamp, Pablo Fernandez-Pernas, et al.Hemasphere|February 24, 2021
Precision Medicine in Hematology 2021: Definitions, Tools, Perspectives, and Open QuestionsPeter Valent, Alberto Orfao, Stefan Kubicek, et al.Cell Death & Disease|October 14, 2016
Increased survival and cell cycle progression pathways are required for EWS/FLI1-induced malignant transformationTahereh Javaheri, Zahra Kazemi, Jan Pencik, et al.Cell Death & Disease|July 25, 2018
Correction: Increased survival and cell cycle progression pathways are required for EWS/FLI1-induced malignant transformationTahereh Javaheri, Zahra Kazemi, Jan Pencik, et al.Cell Death & Disease|August 14, 2019
Retraction Note: Increased survival and cell cycle progression pathways are required for EWS/FLI1-induced malignant transformationTahereh Javaheri, Zahra Kazemi, Jan Pencik, et al.Blood|April 29, 2020
CDK6 is an essential direct target of NUP98 fusion proteins in acute myeloid leukemiaJohannes Schmoellerl, Inês Amorim Monteiro Barbosa, Thomas Eder, et al.Nature Communications|October 20, 2019
A kinase-independent role for CDK8 in BCR-ABL1+ leukemiaIngeborg Menzl, Tinghu Zhang, Angelika Berger-Becvar, et al.Journal of Clinical Pathology|August 30, 2022
Increasing test specificity without impairing sensitivity: lessons learned from SARS-CoV-2 serologyThomas Perkmann, Thomas Koller, Nicole Perkmann-Nagele, et al.Nature Chemical Biology|July 14, 2015
Pharmacological targeting of the Wdr5-MLL interaction in C/EBPα N-terminal leukemiaFlorian Grebien, Masoud Vedadi, Matthäus Getlik, et al.Pageof 8